These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 23398220)

  • 1. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample.
    Lev-Ran S; Le Strat Y; Imtiaz S; Rehm J; Le Foll B
    Am J Addict; 2013 Jan; 22(1):7-13. PubMed ID: 23398220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC).
    Lev-Ran S; Imtiaz S; Rehm J; Le Foll B
    Am J Addict; 2013; 22(2):93-8. PubMed ID: 23414492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Le Foll B
    Am J Addict; 2012; 21(6):531-5. PubMed ID: 23082831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.
    Weinberger AH; Gbedemah M; Wall MM; Hasin DS; Zvolensky MJ; Goodwin RD
    Addiction; 2018 Apr; 113(4):719-728. PubMed ID: 29265574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood maltreatment and substance use disorders among men and women in a nationally representative sample.
    Afifi TO; Henriksen CA; Asmundson GJ; Sareen J
    Can J Psychiatry; 2012 Nov; 57(11):677-86. PubMed ID: 23149283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Goldstein RB; Chou SP; Smith SM; Jung J; Zhang H; Saha TD; Pickering RP; Ruan WJ; Huang B; Grant BF
    J Stud Alcohol Drugs; 2015 May; 76(3):378-88. PubMed ID: 25978823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.
    Shmulewitz D; Greene ER; Hasin D
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1878-900. PubMed ID: 26332166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorders and adoption: findings from a national sample.
    Yoon G; Westermeyer J; Warwick M; Kuskowski MA
    PLoS One; 2012; 7(11):e49655. PubMed ID: 23166740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Victimization and perpetration of intimate partner violence and substance use disorders in a nationally representative sample.
    Afifi TO; Henriksen CA; Asmundson GJ; Sareen J
    J Nerv Ment Dis; 2012 Aug; 200(8):684-91. PubMed ID: 22850303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of substance use among US physicians.
    Hughes PH; Brandenburg N; Baldwin DC; Storr CL; Williams KM; Anthony JC; Sheehan DV
    JAMA; 1992 May; 267(17):2333-9. PubMed ID: 1348789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hasin DS; Stinson FS; Ogburn E; Grant BF
    Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey.
    Roberts RE; Roberts CR; Xing Y
    Drug Alcohol Depend; 2007 Apr; 88 Suppl 1(Suppl 1):S4-13. PubMed ID: 17275212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
    McCabe SE; West BT; Strobbe S; Boyd CJ
    J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Goldstein BI; Levitt AJ
    Bipolar Disord; 2008 Feb; 10(1):67-78. PubMed ID: 18199243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
    Kendler KS; Myers J; Prescott CA
    Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.